Xenon Pharmaceuticals (XENE) Priced

Licenses drugs to uniQure, Teva and Genentech for LPLD, pain and acne.

Health Care - Biotechnology

IPO Performance
Latest Trade $7.75 0.00 (0.0%)
First Day Return 16.7%
Return from IPO -13.9%
 
Xenon Pharmaceuticals IPO News more
  • .
IPO Data
IPO File Date 09/10/2014
Offer Price $9.00
Price Range $10.00 - $12.00
Offer Shares (mm) 4.0
Deal Size ($mm) 36
 
IPO Data
IPO Date 11/04/2014
Offer Price $9.00
Price Range $10.00 - $12.00
Offer Shares (mm) 4.0
Deal Size ($mm) $36
 
Underwriters
more
Business Overview
Licenses drugs to uniQure, Teva and Genentech for LPLD, pain and acne.
Licenses drugs to uniQure, Teva and Genentech for LPLD, pain and acne.
more
Company Data
Headquarters Burnaby, , Canada
Founded 1996
Employees 74
Website www.xenon-pharma.com
 

Performance vs. IPO Index (IPOUSA)